LGALS3 and cancer: To the best of our knowledge, this is the first report on the preparation of 68Ga-labeled E[c(RGDfK)]2-based glycopeptide, which possesses a lactosamine moiety for the detection of αvβ3 integrin and galectin-3 expression in cancer and tumoral endothelial cells with PET imaging.